|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001418,
umls-concept:C0007131,
umls-concept:C0019638,
umls-concept:C0030705,
umls-concept:C0035647,
umls-concept:C0087111,
umls-concept:C0205314,
umls-concept:C0679622,
umls-concept:C0683598,
umls-concept:C1514474,
umls-concept:C1880177,
umls-concept:C1999216
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2011-6-17
|
|
pubmed:abstractText |
High inhibitor of differentiation-1 (Id1) levels have been found in some tumor types. We aimed to study Id1 levels and their prognostic impact in a large series of stages I to IV non-small cell lung cancer (NSCLC) patients. Experiments in cell lines and cells derived from malignant pleural effusions (MPE) were also carried out.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
pubmed-author:AgorretaJackelineJ,
pubmed-author:BehrensCarmenC,
pubmed-author:CalvoAlfonsoA,
pubmed-author:García-FoncillasJesúsJ,
pubmed-author:García-FrancoCarlos ECE,
pubmed-author:Gil-BazoIgnacioI,
pubmed-author:LozanoMaría DMD,
pubmed-author:MontuengaLuis MLM,
pubmed-author:PajaresMaría JMJ,
pubmed-author:PioRubenR,
pubmed-author:Ponz-SarviséMarianoM,
pubmed-author:RedradoMiriamM,
pubmed-author:VinzoJJ,
pubmed-author:WistubaIgnacio III
|
|
pubmed:copyrightInfo |
©2011 AACR.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
17
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4155-66
|
|
pubmed:meshHeading |
pubmed-meshheading:21540238-Adenocarcinoma,
pubmed-meshheading:21540238-Antineoplastic Agents,
pubmed-meshheading:21540238-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:21540238-Cell Line, Tumor,
pubmed-meshheading:21540238-Cell Proliferation,
pubmed-meshheading:21540238-Down-Regulation,
pubmed-meshheading:21540238-Drug Resistance, Neoplasm,
pubmed-meshheading:21540238-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:21540238-Gene Silencing,
pubmed-meshheading:21540238-Humans,
pubmed-meshheading:21540238-Inhibitor of Differentiation Protein 1,
pubmed-meshheading:21540238-Neoplasm Staging,
pubmed-meshheading:21540238-Prognosis,
pubmed-meshheading:21540238-RNA, Messenger,
pubmed-meshheading:21540238-RNA, Small Interfering,
pubmed-meshheading:21540238-Radiation Tolerance,
pubmed-meshheading:21540238-Treatment Outcome
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Inhibitor of differentiation-1 as a novel prognostic factor in NSCLC patients with adenocarcinoma histology and its potential contribution to therapy resistance.
|
|
pubmed:affiliation |
Departments of Oncology, Pathology, and Thoracic Surgery, Clínica Universidad de Navarra; Division of Oncology, Center for Applied Medical Research (CIMA), Pamplona, Spain.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
